AI-generated summary
The authors followed Chinese children with myopia for two years after an initial one-year trial of repeated low-level red-light therapy at 650 nm. Children who continued the therapy showed the least axial elongation and refractive progression, while those who stopped it showed a modest rebound effect. The authors report no self-reported adverse events, and the study was non-randomised in its second year with only 57.3% of eligible children analysed.
- Participants
- 114
- Who or what was studied
- Chinese children with myopia who originally completed a one-year randomised controlled trial; 114 of 199 eligible children were analysed
- Wavelengths
- 650 nm
- Limits stated in the abstract
- Only 57.3% of eligible children were analysed, group sizes were small and unequal (10 to 52 per group), and the second year was not randomised.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 650 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Repeated low-level red light, Myopia. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.